See more : Manawa Energy Limited (MNW.NZ) Income Statement Analysis – Financial Results
Complete financial analysis of PW Medtech Group Limited (1358.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PW Medtech Group Limited, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Murphy Oil Corporation (0K3S.L) Income Statement Analysis – Financial Results
- Hotel Newgrand Co.,Ltd. (9720.T) Income Statement Analysis – Financial Results
- Axcap Ventures Inc. (AXCP.CN) Income Statement Analysis – Financial Results
- Keypath Education International, Inc. (KED.AX) Income Statement Analysis – Financial Results
- L.D.C. S.A. (0RJ6.L) Income Statement Analysis – Financial Results
PW Medtech Group Limited (1358.HK)
About PW Medtech Group Limited
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 675.08M | 536.83M | 271.40M | 247.35M | 362.18M | 310.81M | 286.91M | 319.58M | 515.59M | 608.06M | 457.08M | 331.54M |
| Cost of Revenue | 294.19M | 238.00M | 105.34M | 98.75M | 140.06M | 115.57M | 112.39M | 109.28M | 129.17M | 165.17M | 146.66M | 112.69M |
| Gross Profit | 380.90M | 298.83M | 166.06M | 148.60M | 222.13M | 195.24M | 174.53M | 210.31M | 386.42M | 442.89M | 310.43M | 218.85M |
| Gross Profit Ratio | 56.42% | 55.67% | 61.19% | 60.08% | 61.33% | 62.82% | 60.83% | 65.81% | 74.95% | 72.84% | 67.91% | 66.01% |
| Research & Development | 41.13M | 40.98M | 20.25M | 48.20M | 27.94M | 29.33M | 13.11M | 11.71M | 23.90M | 47.05M | 26.49M | 9.51M |
| General & Administrative | 119.02M | 122.10M | 61.31M | 56.55M | 65.24M | 58.09M | 70.56M | 44.49M | 61.53M | 79.20M | 59.30M | 35.60M |
| Selling & Marketing | 76.09M | 67.47M | 61.78M | 82.67M | 101.16M | 72.92M | 54.79M | 41.70M | 68.56M | 94.22M | 61.94M | 46.82M |
| SG&A | 195.11M | 189.57M | 123.09M | 148.99M | 181.89M | 116.92M | 125.35M | 86.96M | 130.09M | 174.22M | 121.54M | 82.42M |
| Other Expenses | -42.74M | 24.21M | 20.66M | 9.70M | 16.71M | -25.33M | 121.00K | 366.00K | 1.24M | 553.00K | 1.01M | 199.00K |
| Operating Expenses | 193.50M | 175.98M | 514.68M | 483.12M | 107.82M | 61.46M | 131.22M | 84.71M | 146.03M | 238.05M | 196.34M | 87.22M |
| Cost & Expenses | 487.69M | 413.98M | 620.02M | 581.87M | 247.88M | 177.03M | 243.61M | 193.98M | 275.20M | 403.22M | 343.00M | 199.92M |
| Interest Income | 43.83M | 34.90M | 56.73M | 5.13M | 28.50M | 7.21M | 1.77M | 2.24M | 5.00M | 6.48M | 220.00K | 329.00K |
| Interest Expense | 154.00K | 464.00K | 605.00K | 10.67M | 30.12M | 8.61M | 0.00 | 0.00 | 1.25M | 15.74M | 5.02M | 500.00K |
| Depreciation & Amortization | 98.26M | 78.59M | 31.42M | 28.44M | 29.40M | 21.26M | 45.90M | 63.41M | 57.98M | 38.17M | 20.41M | 17.93M |
| EBITDA | 329.48M | 175.49M | 77.98M | 2.94M | 69.27M | 81.85M | 64.42M | 137.15M | 297.67M | 277.96M | 192.81M | 138.15M |
| EBITDA Ratio | 48.81% | 32.69% | 28.73% | 1.19% | 19.13% | 26.33% | 22.45% | 42.92% | 57.73% | 45.71% | 42.18% | 42.68% |
| Operating Income | 187.40M | 98.17M | 47.07M | -24.69M | 40.86M | 61.81M | 44.70M | 117.53M | 239.69M | 239.79M | 172.40M | 128.48M |
| Operating Income Ratio | 27.76% | 18.29% | 17.34% | -9.98% | 11.28% | 19.89% | 15.58% | 36.77% | 46.49% | 39.43% | 37.72% | 38.75% |
| Total Other Income/Expenses | 43.67M | 59.58M | 690.40M | 651.29M | 44.95M | 64.77M | 380.00K | 10.32M | 5.69M | -2.44M | -4.51M | -8.76M |
| Income Before Tax | 231.07M | 157.75M | 737.46M | 626.60M | 85.81M | 126.58M | 45.08M | 127.84M | 245.38M | 211.32M | 113.86M | 119.72M |
| Income Before Tax Ratio | 34.23% | 29.39% | 271.73% | 253.32% | 23.69% | 40.72% | 15.71% | 40.00% | 47.59% | 34.75% | 24.91% | 36.11% |
| Income Tax Expense | 26.04M | 28.88M | 1.65M | 5.21M | 3.84M | 11.06M | 11.30M | 20.21M | 41.15M | 34.69M | 22.86M | 19.54M |
| Net Income | 153.18M | 106.04M | 739.12M | 631.81M | 81.98M | 114.81M | 4.52M | 109.14M | 208.58M | 176.63M | 77.91M | 44.67M |
| Net Income Ratio | 22.69% | 19.75% | 272.34% | 255.43% | 22.64% | 36.94% | 1.58% | 34.15% | 40.46% | 29.05% | 17.04% | 13.47% |
| EPS | 0.10 | 0.07 | 0.47 | 0.40 | 0.05 | 0.07 | 0.00 | 0.07 | 0.12 | 0.11 | 0.06 | 0.04 |
| EPS Diluted | 0.10 | 0.07 | 0.47 | 0.40 | 0.05 | 0.07 | 0.00 | 0.07 | 0.12 | 0.10 | 0.06 | 0.04 |
| Weighted Avg Shares Out | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B | 1.58B | 1.62B | 1.67B | 1.67B | 1.25B | 1.11B |
| Weighted Avg Shares Out (Dil) | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B | 1.58B | 1.63B | 1.69B | 1.72B | 1.28B | 1.11B |
Source: https://incomestatements.info
Category: Stock Reports